Effects of Memantine on Cerebrospinal Fluid Biomarkers of Neurofibrillary Pathology - Glodzik, Lidia; De Santi, Susan; Rich, Kenneth E.; Brys, Miroslaw; Pirraglia, Elizabeth; Mistur, Rachel; Switalski, Remigiusz; Mosconi, Lisa; Sadowski, Martin; Zetterberg, Henrik; Blennow, Kaj; de Leon, Mony J. (Journal of Alzheimer's disease, 2009)
Keywords: Aged; Alzheimer Disease - cerebrospinal fluid; Alzheimer Disease - drug therapy; Alzheimer Disease - pathology; Antiparkinson Agents - pharmacology; Antiparkinson Agents - therapeutic use; Biomarkers - cerebrospinal fluid; Brain - pathology; Cognition Disorders - diagnosis; Cognition Disorders - drug therapy; Cognition Disorders - pathology; Female; Humans; Male; Memantine - pharmacology; Memantine - therapeutic use; Neurofibrillary Tangles - pathology; Neuropsychological Tests; Phosphorylation - drug effects; Psychiatry; Psykiatri; Severity of Illness Index; Spinal Puncture; tau Proteins - metabolism; total tau; memantine; Alzheimer's disease; biomarkers; cerebrospinal fluid; phosphorylated tau